EBOS Group Stock

EBOS Group EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of EBOS Group (EBO.NZ) as of Jul 27, 2026 is 570.00 M AUD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 611.41 M AUD — a change of -6.77% (lower).

EBITDA

570.00 MAUD

YoY

-6.77%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of EBOS Group is 2026 570.00 M AUD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of EBOS Group was 2025 611.41 M AUD. It decreases by -6.77% lower compared to the previous year.
Access this data via the Eulerpool API

EBOS Group Stock analysis

What does EBOS Group do? The EBOS Group was founded in New Zealand in 2000 and has since grown to become one of the largest healthcare companies in the region. The company's business model is to provide solutions for the healthcare industry, ranging from products for pharmacies, hospitals, and medical practices to healthcare services. The company is divided into several divisions, including healthcare distribution, dental, and healthcare services. The healthcare distribution division focuses on distributing pharmaceutical products, medical devices, and other healthcare items to healthcare facilities. This includes surgical instruments and oncology products. The dental division specializes in selling and distributing dental products, such as instruments for dentists and consumables like gloves, implants, and floss. They also offer services for dentists, including a dental practice built in partnership with another company. The healthcare services division includes the distribution of home care and healthcare products, as well as the rental of medical equipment like wheelchairs and beds. EBOS Group also provides services such as consultation and training for patients, caregivers, and healthcare providers. With a strong emphasis on quality and customer satisfaction, EBOS Group has a successful track record and has acquired and developed several companies in the region. Their products help improve patient health and contribute to reducing healthcare costs. The company plays a vital role in the healthcare products and services market. The EBOS Group's diverse divisions and wide range of products secure its position as an important player in the healthcare industry. EBOS Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about EBOS Group stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of EBOS Group is 570.00 M AUD in 2026.

Access this data via the Eulerpool API

Income Statement — EBOS Group

All Key Metrics — EBOS Group